Prognostic Significance of Endothelial Activation and Stress Index in Mantle Cell Lymphoma.
10.19746/j.cnki.issn.1009-2137.2025.04.018
- Author:
Xin-Yue ZHOU
1
;
Zhi-Qin YANG
1
;
Jin HU
1
;
Feng-Yi LU
1
;
Qian-Nan HAN
1
;
Huan-Huan ZHAO
1
;
Wen-Xia GAO
1
;
Yu-Han MA
2
;
Hu-Jun LI
1
;
Zhen-Yu LI
1
;
Kai-Lin XU
1
;
Wei CHEN
1
Author Information
1. Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China.
2. Department of Hematology, Suqian First People's Hospital, Suqian Clinical College of Xuzhou Medical University, Suqian 223800, Jiangsu Province, China.
- Publication Type:Journal Article
- Keywords:
mantle cell lymphoma;
endothelial activation and stress index;
prognosis
- MeSH:
Humans;
Lymphoma, Mantle-Cell/pathology*;
Prognosis;
Retrospective Studies;
Male;
Female;
Middle Aged;
Aged;
ROC Curve
- From:
Journal of Experimental Hematology
2025;33(4):1051-1056
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the predictive value of endothelial activation and stress index (EASIX) for the prognosis of patients with mantle cell lymphoma (MCL).
METHODS:A retrospective analysis was conducted to assess prognosis and compare the clinical features of patients diagnosed with MCL who were admitted to the Affiliated Hospital of Xuzhou Medical University from January 2010 to June 2023, had therapeutic indications and received standard treatment.
RESULTS:A total of 66 patients were included and divided into high EASIX group and low EASIX group, according to a cutoff value of 0.97 determined by the receiver operating characteristic (ROC) curve. Multivariate Cox regression analysis showed that prealbumin <0.2 g/L, high EASIX, and ECOG PS score ≥2 were independent risk factors influencing overall survival (OS) in MCL patients. The median OS of patients in the high and low EASIX group was 13.0 and 37.5 months, and the median progression-free survival was 8.8 and 26.0 months, respectively. The proportions of patients with ECOG PS score ≥2 and prealbumin <0.2 g/L at onset significantly increased in the high EASIX group compared to those in the low EASIX group.
CONCLUSION:At the time of initial diagnosis, EASIX can serve as an independent prognostic indicator impacting OS in patients with MCL. Furthermore, patients in the high EASIX group experience a poorer prognosis and shorter survival duration compared with those in the low EASIX group.
